4DX 0.94% 52.5¢ 4dmedical limited

Research, page-799

  1. 2,160 Posts.
    lightbulb Created with Sketch. 614
    Screenshot (448).png

    Will be interesting to see how close they can nail this time wise.

    Detailed Description:

    This is a pilot study to determine the feasibility and utility of Novel Functional Lung Imaging and Ventilation (4DxV) Analysis software in measurement of lung ventilation abnormalities and diagnosis of CLAD after lung transplantation. 4DxV is a technology developed by 4Dx (4Dx Limited, Melbourne, Australia and Los Angeles, CA) and is a novel computational approach to the data obtained from standard fluoroscopic imaging that measures tissue motion of the lung at all locations and in all phases of breath.

    These motion measurements are used to calculate 4-dimensional ventilation (4DxV) of lung tissue to provide variety of outputs. The investigators will establish the sensitivity, specificity, and accuracy of this technology in diagnosis of CLAD compared to CT scan and pulmonary function results in patients with a known diagnosis of CLAD based on established diagnostic criteria.

    The investigators will test the following hypotheses:

    ♦   4DxV scans will be able to detect quantitative ventilation abnormalities in patients with established CLAD and the severity of the abnormalities will correlate with severity of PFT decline
    ♦   4DxV will be able to diagnose patients with CLAD of the bronchiolitis obliterans syndrome (BOS) phenotype grades 0 (CLAD free) vs grades 1-3
 
watchlist Created with Sketch. Add 4DX (ASX) to my watchlist
(20min delay)
Last
52.5¢
Change
-0.005(0.94%)
Mkt cap ! $215.4M
Open High Low Value Volume
52.5¢ 53.0¢ 51.5¢ $146.0K 279.1K

Buyers (Bids)

No. Vol. Price($)
3 21156 52.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.0¢ 310 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
4DX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.